Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Repligen Promises To Be A Cash Flow Machine
Seeking Alpha
Wednesday, April 3, 2013 - 10:53am
tags:
Repligen
Elan completes sale of Tysabri stake to Biogen
Reuters
Wednesday, April 3, 2013 - 10:51am
tags:
Tysabri, Elan, Biogen Idec, MS, multiple sclerosis
Why Anacor Is Poised to Pull Back
Motley Fool
Wednesday, April 3, 2013 - 10:50am
tags:
Anacor
A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wednesday, April 3, 2013 - 10:48am
tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novo Nordisk, Merck, Incretin
Biosimilars Could Be An Unlikely Boost For Pfizer
Seeking Alpha
Wednesday, April 3, 2013 - 10:46am
tags:
biosimilars, Pfizer, trastuzumab, Apixaban, tofacitinib
Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources
Reuters
Wednesday, April 3, 2013 - 9:48am
tags:
Pfizer, Novartis, Brazil, Abbott Labs, Ache Laboratorios Farmaceuticos, M&A
Does The World Want, Much Less Need, A New Erectile Dysfunction Drug?
Forbes
Wednesday, April 3, 2013 - 9:46am
tags:
Avanafil, erectile dysfunction, Vivus, Stendra
Zalicus: Renewing Partnership With Novartis Will Be Vital For 2013 Revenues
Seeking Alpha
Wednesday, April 3, 2013 - 9:41am
tags:
Novartis, Zalicus, Z160
Valeant sweetens bid for Obagi Medical
Reuters
Wednesday, April 3, 2013 - 8:46am
tags:
Obagi Medical Products, Valeant Pharmaceuticals, M&A, Merz
Drugmakers to Benefit From Obama's Brain Initiative
Bloomberg
Wednesday, April 3, 2013 - 8:45am
tags:
Obama, brain research, Pfizer, Roche, Eli Lilly
Pfizer to Pay Bind Up to $210 Million in Nanotechnology Deal
Bloomberg
Wednesday, April 3, 2013 - 8:40am
tags:
Nanotechnoogy, Pfizer, Bind Therapeutics
U.S. trade office reviewing India's Supreme Court drug ruling
Reuters
Wednesday, April 3, 2013 - 8:39am
tags:
Novartis, Glivec, patents, India
Isis Publishes Encouraging Data
Yahoo/Zacks
Wednesday, April 3, 2013 - 8:38am
tags:
Isis Pharmaceuticals, antisense
AstraZeneca's MedImmune unit acquires AlphaCore Pharma
Yahoo/Fly on the Wall
Wednesday, April 3, 2013 - 8:37am
tags:
AstraZeneca, M&A, MedImmune, AlphaCore Pharma
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tuesday, April 2, 2013 - 10:58am
tags:
Arena Pharmaceuticals, Zogenix, Delcath, Aveo Pharmaceutical, Vivus, Titan Pharmaceuticals, Bristol-Myers Squibb, Merck, Gilead, AbbVie, Amarin, Achillion, Sangamo BioSciences, Raptor Pharmaceuticals, Vertex Pharmaceuticals, NewLink Genetics, AstraZeneca, Rigel, Depomed, Biogen Idec, Sucampo, Dendreon, Valeant Pharmaceuticals, GSK, Aegerion
Zalicus Granted Key Formulation Patent for Z160
Yahoo
Tuesday, April 2, 2013 - 10:54am
tags:
Z160, Zalicus
Obagi Medical gets higher offer from Merz Pharma
Reuters
Tuesday, April 2, 2013 - 10:53am
tags:
M&A, Merz, Obagi Medical Products, Valeant Pharmaceuticals
3 Contenders With Novel, Non-Invasive Treatments For Cancer
Seeking Alpha
Tuesday, April 2, 2013 - 10:26am
tags:
AngioDynamics, cancer, OncoSec, Agenus, QS-21, NeoPulse, ImmunoPulse
Immunomedics settles Finra arbitration proceedings
The Fly on the Wall
Tuesday, April 2, 2013 - 10:23am
tags:
Finra, Immunomedics
Will AMR-001 Lead Neostem To The Promised Land?
Seeking Alpha
Tuesday, April 2, 2013 - 10:11am
tags:
AMR-001, NeoStem

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.